Innovation Saving Lives

We are a biotechnology company with a proprietary biomarker discovery platform, EpiSwitch™, based on the latest advances in gene expression,non-coding RNA and epigenetics.

Episwitch™ biomarkers based on chromosomal conformation signatures are a critical cog in personalised medicine.

Technology to select the right drug at the right dose at the right time for the right patient.

Recent Publications on Chromosome Conformation Signatures

Nucleome Analysis Reveals Structure-function Relationships for Colon Cancer.

Seaman L et. al.
Mol Cancer Res.

Topologically associated domains: a successful scaffold for the evolution of gene regulation in animals.

Acemel RD et. al.
Wiley Interdiscip Rev Dev Biol.

Software tools for visualizing Hi-C data.

Yardimici GG et. al.
Genome Biology

Capturing genomic relationships that matter.

Osborne CS et. al.
Chromosome Research

Transcription factors operate TATA switches via rotational remodeling of local columnar chromatin structure.

Trifonov EN
J Biomol Struct Dyn.